# Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major

> **NCT00800761** · PHASE4 · COMPLETED · sponsor: **Ospedale Microcitemico**

## Conditions studied

- Iron Overload
- Cardiomyopathy

## Interventions

- **DRUG:** Deferoxamine and Deferiprone
- **DRUG:** Deferoxamine

## Key facts

- **NCT ID:** NCT00800761
- **Lead sponsor:** Ospedale Microcitemico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** — (—)
- **Last updated:** 2008-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800761, "Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00800761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*